Search
for
Sort by
Research 121–150 of 201
- Malignant Melanoma and Its Stromal Nonimmune Microecosystem
- Proteolysis‐Targeting Chimera (PROTAC): Current Applications and Future Directions
- Health-related quality of life with sacituzumab govitecan in HR+/HER2− metastatic breast cancer in the phase III TROPiCS-02 trial
- Open-Label, Randomized, Multicenter, Phase III Study Comparing Oral Paclitaxel Plus Encequidar Versus Intravenous Paclitaxel in Patients With Metastatic Breast Cancer
- Tissue Resident Foxp3+ Regulatory T Cells: Sentinels and Saboteurs in Health and Disease
- Hydrogels Modulating the Microbiome: Therapies for Tissue Regeneration with Infection Control
- Chitosan Hydrogel as Tissue Engineering Scaffolds for Vascular Regeneration Applications
- ‘Malignant melanoma microecosystem’: Immunohistopathological insights into the stromal cell phenotype
- Sustained hair regrowth with continued ritlecitinib treatment through week 48 in patients with alopecia areata with or without early target responses: Post hoc analysis of the ALLEGRO phase 2b/3 trial
- Efficacy and safety of ritlecitinib, an oral JAK3/TEC family kinase inhibitor, in adolescent and adult patients with alopecia totalis and alopecia universalis
- Interstitial pneumonia with autoimmune features: challenges and controversies
- Emerging Strategies in Smart Nano-PROTAC for Stimuli-Responsive Protein Degradation and Precision Cancer Therapy
- Mutational spectrum associated with oculocutaneous albinism and Hermansky-Pudlak syndrome in nine Pakistani families
- The Role of Hormones in Hidradenitis Suppurativa: A Systematic Review
- Clinical Manifestations of Hyperandrogenism and Ovulatory Dysfunction Are Not Associated with His1058 C/T SNP (rs1799817) Polymorphism of Insulin Receptor Gene Tyrosine Kinase Domain in Kashmiri Women with PCOS
- Dermal EZH2 orchestrates dermal differentiation and epidermal proliferation during murine skin development
- Acetyl-CoA synthesis in the skin is a key determinant of systemic lipid homeostasis
- Neurotoxins Acting at Synaptic Sites: A Brief Review on Mechanisms and Clinical Applications
- Spectrum and Impact of Reported Side Effects of Omalizumab in Patients With Chronic Urticaria: A Long‐Term Multicentre Real‐World Study
- European expert consensus statement on the systemic treatment of alopecia areata
- Inhibition of T-cell activity in alopecia areata: recent developments and new directions
- Proteolysis‐targeting chimeras in cancer therapy: Targeted protein degradation for next‐generation treatment
- Targeted radionuclide therapy for head and neck squamous cell carcinoma: a review
- Cell type‐specific actions of thyroid hormones in nonalcoholic steatohepatitis and liver fibrosis
- Fabrication and in vitro evaluation of silk fibroin-folic acid decorated paclitaxel and hydroxyurea nanostructured lipid carriers for targeting ovarian cancer cells: A double sword approach
- Berberine-based strategies: novel delivery systems bring out new potential for wound healing
- Selective androgen receptor modulators: a critical appraisal
- Statement from the frontal fibrosing alopecia international expert alliance: SOFFIA 2024
- Circulating monocytes as a marker of response to adalimumab in patients with hidradenitis suppurativa: A single institution, real-world cohort study
- A retrospective clinical and laboratory analysis including vitamin D and antinuclear antibodies in central centrifugal cicatricial alopecia and nonscarring alopecia in African Americans